1. Alós, J.I., Aracil, B., Oteo, J. & Gómez-Garcés, J.L. (2003) Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J. Antimicrob. Chemother., 51, 333-337.
2. Arai, K., Hirakata, Y., Yano, H., Kanamori, H., Endo, S., Hirotani, A., Abe, Y., Nagasawa, M., Kitagawa, M., Aoyagi, T., Hatta, M., Yamada, M., Nishimaki, K., Takayama, Y., Yamamoto, N., et al. (2011) Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution. J. Antimicrob. Chemother., 66, 494-498.
3. Ardanuy, C., Domenech, A., Rolo, D., Calatayud, L., Tubau, F., Ayats, J., Martín, R. & Liñares, J. (2010) Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J. Antimicrob. Chemother., 65, 634-643.
4. Baker, G.C., Smith, J.J. & Cowan, D.A. (2003) Review and re-analysis of domain-specific 16S primers. J. Microbiol. Methods, 55, 541-555.
5. Beall, B., Facklam, R. & Thompson, T. (1996) Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol., 34, 953-958.